![Kimberley S. Gannon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kimberley S. Gannon
Keine laufenden Positionen mehr
Profil
Kimberley S.
Gannon worked as a Senior Director-Biology at Predix Pharmaceuticals, Inc., Senior VP-Preclinical Research & Development at Proclara Biosciences, Inc., Vice President-Research & Development at Ischemix, Inc., Head-US Operations at Eolas Biosciences Co., Ltd., and Chief Scientific Officer at Lysogene SA. She received a doctorate degree from Florida State University in 1994.
Ehemalige bekannte Positionen von Kimberley S. Gannon
| Unternehmen | Position | Ende |
|---|---|---|
| LYSOGENE | Technik-/Wissenschafts-/F&E-Leiter | 02.05.2018 |
Eolas Biosciences Co., Ltd. | Corporate Officer/Principal | - |
Ischemix, Inc.
 Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs | Corporate Officer/Principal | - |
Predix Pharmaceuticals, Inc.
 Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Corporate Officer/Principal | - |
Proclara Biosciences, Inc.
 Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Provides treatment of chronic neurodegenerative diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Kimberley S. Gannon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Health Technology |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Provides treatment of chronic neurodegenerative diseases | Health Technology |
Florida State University
 Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs | Health Technology |
Eolas Biosciences Co., Ltd. | |
Lysogene SA
 Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
